Diabetes ECHO
TRAINING AND SUPPORT FOR DIABETES MANAGEMENT PROFESSIONALS
Diabetes ECHO is designed to provide an educational and consultative link between diabetes specialists and community clinicians throughout Louisiana. Its goal is to increase access to diabetes education in urban and rural communities statewide. Diabetes ECHO uses the ECHO model™ to develop knowledge and capacity amongst community-based providers through the use of technology to leverage scarce resources, share best practices to reduce disparities, case-based learning to master complexity, and monitoring outcomes using an automated web-based platform.
Interactively, primary care clinicians and advanced practitioners join to become experts in the care and management of diabetes and diabetes-related conditions so that their patients can receive timely treatment in their own communities with an end-goal of improved healthcare outcomes.
Each virtual session includes didactic teaching for imparting knowledge to learners and provide consultations through case review of patients living with diabetes.
ECHO functions as a “hub and spoke” model with an interdisciplinary, team-based approach. Well-Ahead Louisiana Diabetes ECHO team serves as the “hub” of specialists, including an Endocrinologist, Internal Medicine Physician, a Certified Diabetes Educator, Nurse Practitioner, Cardiologist, and a Podiatrist. All who register to join form a Community of Practice and become “spokes” of the model.


2026 Diabetes ECHO registration is open!
Registration period is Monday, November 17, 2025 to Monday, January 12, 2026. First session begins January 29, 2026 at 12 noon (CST)
The scheduled ECHO sessions are synchronous and interactive. It encompasses the ECHO ethos of “All teach, All learn” sharing network. During ECHO sessions, providers present de-identified patient cases to expert hub team members who mentor the learners to manage patients with common complex diabetes related conditions.
One-hour sessions are held every other week. Physicians, physician assistants, nurses, nurse practitioners and pharmacists are able to obtain continuing education credits for participation in Diabetes ECHO sessions.
110
cases presented
115
total sessions
CE credits issued
691
158
providers trained
What to Expect
Structure of an ECHO Session:
- Introductions
- Case presentation
- Recommendations
- Didactic presentation
Diabetes ECHO Objectives:
- Establishes a Community of Practice by engaging in a virtual community with their peers.
- De-monopolizes knowledge and amplifies the capacity to provide best practice care for underserved people in rural Louisiana.
- Provides front-line clinicians with up-to-date knowledge and support they need to manage patients with complex conditions in the patients’ own communities.
- Increases provider confidence and self-efficacy in treating patients with diabetes.
Download the Diabetes ECHO Participant Guide to learn more.
“I am better equipped to have those conversations with my patients and refer when appropriate. This session was extremely interactive and provided extensive information”.
Meet the Hub Team

Christine Castille, FNP-C, BC-ADM, CDE
-
About
Christine Castille is a Family Nurse Practitioner, board certified in Advanced Diabetes Management. Christine is passionate about partnering with healthcare providers, staff, and patients to reach quality healthcare goals. As a nurse practitioner and healthcare consultant, her career has included a focus on multiple aspects of diabetes and related conditions such as hypertension, renal disease, and obesity as well as working for and collaborating with payors and ACOs. Recently Christine’s passion for supporting healthcare providers, empowering patients and researching integral aspects of patient adherence has led her to work with VMS bio- marketing.

Anthony Decuir, Jr., DPM
-
About
Dr. Anthony Decuir was born and raised in New Orleans and attended Brother Martin High School and Xavier University of Louisiana. He attended Podiatry School in Chicago at the Dr. William M. Scholl College of Podiatric Medicine and received his Podiatric training at the University of Texas Health Science Center at San Antonio. After practicing for one year in the New Orleans area, he moved to Baton Rouge, where he has practiced for the past eighteen years.

Satish Gadi, MD, FACC, FSCAI
-
About
Dr. Satish Gadi is an interventional cardiologist who has been practicing in Baton Rouge since 2010. He did much of his training including residency, fellowship, etc. in New York and now works with the Cardiovascular Institute of the South which has been serving Southern Louisiana for 35 plus years. Dr. Gadi in addition to being a cardiologist, has a special interest in PAD—both diagnosis and management.

Amne Borghol, PharmD, BCPS
-
About
Dr. Amne Borghol is currently a Clinical Professor of Pharmacy in the Division of Clinical and Administrative Sciences (DCAS) at Xavier University College of Pharmacy in New Orleans and Clinical Associate Professor of Medicine (Gratis) at Louisiana State University Health Sciences Center, School of Medicine, Department of Medicine, section of Hospital Medicine. Dr. Borghol received her Doctor of Pharmacy from Xavier University, New Orleans, Louisiana. Dr. Borghol completed an American Society of Hospital Pharmacists General Pharmacy Practice Residency at Ochsner Clinic Foundation, New Orleans, Louisiana. She is a Licensed Pharmacist registered, in the states of Louisiana and Texas. Dr Borghol received board certified pharmacotherapy specialty (BCPS) in December 2013.

Dragana Lovre, MD
-
About
Dr. Dragana Lovre is an Assistant Professor of Medicine at Tulane University School of Medicine (Section of Endocrinology), where she also completed her Clinical Endocrinology Fellowship. Dr. Lovre is board certified in internal medicine and endocrinology. Her clinical and research interests focus on cardiovascular complications of diabetes with special interest in women’s health and obesity. She is involved in “Diabetes is Primary Program” by the American Diabetes Association, which delivers easily accessible continuing education to meet the needs of busy primary care providers, and also clinical trials in diabetes at Tulane University.

Vy Anh Mai, MD, MS
-
About
Dr. Vy Anh Mai received a Bachelor of Arts in Biology and her Doctor of Medicine degree at the University of Missouri-Kansas City School of Medicine in Kansas City, Missouri. She also obtained a Master of Science in Clinical Research Methods degree at Tulane University School of Medicine. Dr. Mai joined the Section of General Internal Medicine as an Assistant Professor of Internal Medicine and Pediatrics in 2019. Dr. Mai practices primary care at Tulane’s Uptown Multispecialty Clinic and actively sees patients of all ages. She has an interest in academic medicine and supervises residents in the Internal Medicine/Pediatrics clinic.
2023 Diabetes ECHO Schedule
| Date | Topic |
|---|---|
| December 14, 2023 | Balancing patients with T2DM and CKD |
2026 Diabetes ECHO Sessions
-
Session 1: Classification & Diagnosis of Diabetes (T1 vs T2)
- January 29, 2026
- Dragana Lovre, MD
-
Session 2: ADA Standards of Care in Diabetes—2026
- February 12, 2026
- Meeta Bhalla, MD
-
Session 3: Lifestyle Medicine for Diabetes Management and Prevention
- February 26, 2026
- Christine Castille, FNP-C, BC- ADM, CDCES
-
Session 4: Exploring the Spectrum of Diabetes and Its Causes
- March 12, 2026
- Dragana Lovre, MD
-
Session 5: From Barriers to Balance: How Social Factors Influence Living Well with Diabetes
- March 26, 2026
- Speaker to be announced
-
Session 6: Optimizing Type 1 Diabetes Care: Pharmacologic Innovations and Challenges
- April 9, 2026
- Saige Clark, PharmD – XULA
-
Session 7: Hypertension Management for Patients with Diabetes
- April 23, 2026
- Vy Anh Mai, MD
-
Session 8: Hyperlipidemia Management for Patients with Diabetes
- May 7, 2026
- Vy Anh Mai, MD
-
Session 9: Cardiovascular Risks Assessment and Treatment Options
- May 21, 2026
- Satish Gadi, MD
-
Session 10: Understanding and Managing Diabetes-Related Chronic Kidney Disease
- June 4, 2026
- Brooks Robey, MD
-
Session 11: Peripheral Artery Disease in Diabetes: Risk, Recognition, and Management
- June 18, 2026
- Satish Gadi, MD
-
Session 12: A Practical Approach to Diabetic Neuropathy
- July 2, 2026
- Anthony Decuir, MD
-
Session 13: Diabetes Connection: Preventing Stroke and Preserving Cognition
- July 16, 2026
- Anne Foundas, MD
-
Session 14: Pharmacologic Strategies in Type 2 Diabetes
- July 30, 2026
- Amne Borghol, PharmD
-
Session 15: SGLT-2 Inhibitors in Practice: What Clinicians Need to Know
- August 13, 2026
- Shaveta Gupta, MD
-
Session 16: Where Does Pioglitazone Fit Today? A Practical Review
- August 27, 2026
- Vivian Fonseca, MD
-
Session 17: GLP-1 Receptor Agonists: Evidence, Efficacy, and Evolving Roles
- September 10, 2026
- Shaveta Gupta, MD
-
Session 18: Navigating Patient Resources: Patient Assistance Programs
- September 24, 2026
- Lakeisha Williams, PharmD
-
Session 19: Integrating Diabetes Technology into Everyday Management
- October 8, 2026
- Susie Villalobos, MPH, RDN, LDN, CDCES
-
Session 20: Diabetes Nutrition and Carb Counting Made Simple: For the Holidays and Beyond
- October 22, 2026
- Anna Kiefer, MS, RD, LDN, CDCES
-
Session 21: DSMES: Improved Health Outcomes for Patients with Diabetes
- November 5, 2026
- Susie Villalobos, MPH, RDN, LDN, CDCES
-
Session 22: 2026 ADA National Conference Updates
- November 19, 2026
- Vivian Fonseca, MD
-
Session 23: Improving Diabetes Medication Adherence Outcomes
- December 3, 2026
- Christine Castille, FNP-C, BC-ADM, CDCES
-
2025 Diabetes ECHO Session Archives
Session 1: Introduction to Diabetes ECHO Classification & Diagnosis of Diabetes (T1 vs T2)
Session 2: Standards of Care in Diabetes—2025
Session 3: Social Determinants of Health (SDOH) in relation to Diabetes
Session 4: T1DM screening and management
Session 5: Pharmacologic Therapy for Type 1 Diabetes
Session 6: Obesity & Weight Management for people with Type 2 Diabetes
Session 7: Pharmacologic Therapy for Type 2 Diabetes
Session 8: Review of SGLT-2 Inhibitors
Session 9: Review of Pioglitazone and more
Session 10: Review of GLP-1 Receptor Agonists (Retinopathy info)
Session 11: Navigating Patient Resources: Patient Assistance Programs
Session 12: Diabetes Technology: CGMs and Insulin Pumps
Session 13: DSMES: Improved health outcomes for patients with diabetes
Session 14: Nutrition & Carb Counting: Healthy diet for people with Diabetes
Session 15: Lifestyle Medicine for Diabetes Management /Prevention
BONUS: Foot Care and Diabetic Neuropathy
Session 16: Improving Diabetes Medication Adherence Outcomes
Session 17: Hypertension and Hyperlipidemia Management for Patients with Diabetes
Session 18: Cardiovascular Risks Assessment and Treatment Options
Session 19: Diabetes-Related CKD
Session 20: Peripheral Artery Disease and Diabetes
Session 21: Heart Failure, Diabetes and SGLT2 Use
Session 22: Brain (stroke, TIA) and cognitive effects
- DATE: 12/11/2025
- SPEAKER: Robert Galagan
-
2024 Diabetes ECHO Session Archives
Session 1: Introduction to ECHO, Classification & Diagnosis of Diabetes (T1 vs T2)
Session 2: Social Determinants of Health (SDOH) Diabetes
Session 3: Motivational Interviewing & Medication Adherence
Session 4: Standards of Care in Diabetes—2024
Session 5: Nutrition & Carb Counting: Healthy Diet for People with Diabetes
Session 6: Obesity & Weight Management for People with Type 2 Diabetes
Session 7: Diabetes Prevention – During Your Clinic Visit
Session 8: Pharmacologic Therapy for Type 1 Diabetes
Session 9: Pharmacologic Therapy for Type 2 Diabetes
Session 10: Diabetes Technology: CGMs and Insulin Pumps
Session 11: SGLT-2 Inhibitors and GLP-1 Agonists
Session 12: Hypertension and Hyperlipidemia Management for Patients with Diabetes
Session 13: Neuropathy
Session 14: Cardiovascular Risks and Treatment Options
Session 15: Peripheral Artery Disease and Diabetes
Session 16: Retinopathy: GLP-1 RA effects on retina
Session 17: Brain (stroke, TIA) and cognitive effects
Session 18: DSMES: Improved Health Outcomes for Patients with Diabetes
Session 19: Diabetes-Related CKD
Session 20: Diabetes Heart Failure and SGLT2 Use
Session 21: Nonalcoholic Fatty Liver Disease (NAFLD)
-
2023 Diabetes ECHO Session Archives
Session 1: Introduction: What is ECHO?
Session 2: Pharmacologic Therapy for Type 2 Diabetes
Session 3: Pharmacologic Therapy for Type 1 Diabetes
Session 4: Social Determinants of Health
Resources:
Session 5: Type 2 Diabetes Guidelines and Comprehensive Treatment Plans
Session 6: Review of the Algorithm for Adding Different Medications in DM
Session 7: Insulin Therapies
Session 8: Cardiovascular Disease
Session 9: Nutrition and Carb Counting
Session 10: Hypertension and Hyperlipidemia Management for Patients with Diabetes
Resource:
Session 11: Diabetic Foot Care
Session 12: CGMS and Insulin Pumps
Session 13: Obesity Management with Type 2 Diabetes Population
Session 14: Chronic Kidney Disease and SGLT-2
Session 15: Diabetes Mellitus Neuropathy
Session 16: Knowing Your Audience: Hypoglycemia Treatment
Resources:
- Diabetes Educator Tip Sheet
- Diabetes Educator Tip Sheet Spanish Version
- Walgreens Prescriptions Savings Club
- Walmart Prescriptions
Session 17: Peripheral Artery Disease
Resource:
Session 18: Special Cases and Considerations
Session 19: Nonalcoholic Fatty Liver Disease
Session 20: Helping Patients Stay on Track During the Holidays
Session 21: Type 1 vs Type 2 Refresher
Session 22: Diabetes Self-Management Education
Session 23: Balancing Patients with Diabetes and CKD
-
2022 Diabetes ECHO Session Archives
Session 1: What is ECHO?
Session 2: Types of Diabetes: Causes, Identification, and More
- Presentation Recording
- Presentation Slides
- Resources:
Session 3: Nutrition and Carb Counting
Session 4: Knowing Your Audience: Hypoglycemia Management Individualized Treatment Goals
- Presentation Recording
- Presentation Slides
- Resources:
Session 5: 2022 Diabetes Management Updates
Session 6: Pharmacologic Therapy for Type 1 Diabetes
Session 7: Type 1 Diabetes
- Presentation Recording
- Presentation Slides
- Resources:
Session 8: Cardiovascular Risks and Treatment Options
Session 9: Diabetic Foot Care
- Presentation Recording
- Presentation Slides
- Resources:
Session 10: Psychological Considerations of Obesity and Diabetes
- Presentation Recording
- Presentation Slides
- Resources:
Session 11: Hypertension and Hyperlipidemia Management for Patients with Diabetes
Session 12: SGLT-2 Inhibitors and Diabetic Kidney Disease
- Presentation Recording
- Presentation Slides
- Resources:
Session 13: Diabetic Peripheral Neuropathy
Session 14: Obesity & Metabolic Surgery Benefits and Risks For The Treatment Of Type 2 Diabetes
Session 15: Insulin Treatment of Diabetes Mellitus
Session 16: Nonalcoholic Fatty Liver Disease (NAFLD)
- Presentation Recording
- Presentation Slides
- Resource:
Session 17: Continuous Glucose Monitors and Insulin Pumps
Session 18: Social & Cultural Implications Implicit Bias in Health Care
Session 19: Diabetes Self Management and Support
Session 20: SGLT-2 Inhibitors—Fast Facts for Louisiana Providers
Session 21: Diabetes Medications—Case Based Approach Care
Session 22: Managing Glucose and Social Challenges Through the Holidays
Session 23: Special Causes and Considerations
Session 24: Motivational Interviewing
-
2021 Diabetes ECHO Session Archives
Session 1: What is ECHO?
Session 2: Types of Diabetes: Causes, Identification, and More
Session 3: Community Health Workers
- Presentation Recording
- Presentation slides are unavailable.
Session 4: Pharmacologic Therapy for Type 2 Diabetes
Session 5: Pharmacologic Therapy for Type 1 Diabetes
Session 6: Diabetes Guidelines in Your Office
Session 7: Obesity Management for Type 2 Diabetes
Session 8: Metabolic Surgery Benefits and Risks
Session 9: Insulin Therapies
Session 10: Know Your Audience
Session 11: Hypoglycemia Management
Session 12: Cardiovascular Risks and Treatment Options
Session 13: Diabetic Foot Care
Session 14: Diabetic Kidney Disease
Session 15: Diabetic Peripheral Neuropathy
Session 16: Obesity, Patient Engagement
Session 17: Hypertension and Hyperlipidemia Management
Session 18: Health Literacy and Numeracy in Diabetes Care
Session 19: Diabetes Self-Management Education & Support
Session 20: The National Diabetes Prevention Program
Session 21: Managing Challenges Through the Holidays
Session 22: Vaccine Recommendations in Diabetes
Session 23: Diabetes Care in the Hospital
Session 24: Diabetes in Pregnancy





